Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
10.08.23
/
50%
€37.03
Target price
10.08.24
€58.92
Performance (%)
-45.07%
Price
17:48
€20.34
Summary
This prediction is currently active. Massive losses of -45.07% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 10.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -16.458% | -16.458% |
| iShares Core DAX® | -0.683% | 1.890% |
| iShares Nasdaq 100 | 0.335% | 4.631% |
| iShares Nikkei 225® | -1.486% | -2.361% |
| iShares S&P 500 | -0.523% | 2.324% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€34.13
13.09.23
13.09.23
€60.55
13.09.24
13.09.24
-40.40%
17:48
17:48
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-42.03%
17:48
17:48